Diagnosis and genotype-phenotype correlations in early life epilepsy and CDKL5 disorder
Diagnosis and genotype-phenotype correlations in early life epilepsy and CDKL5 disorder
批准号:
10377934
负责人:
Heather Elisa Olson
金额:
$19.82万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2024-03-31
关键词:
AddressAgeAwardBasic ScienceBostonBrainCDKL5 disorderCategoriesChildChildhoodClinicClinicalClinical ResearchClinical SciencesClinical TrialsClinical Trials DesignCohort AnalysisCollaborationsComplementControl GroupsCyclin-Dependent KinasesDataDatabasesDevelopmentDevelopment PlansDiagnosisDiseaseDoctor of MedicineElectroencephalographyElectrophysiology (science)EpidemiologyEpilepsyEtiologyEvaluationFutureGenesGeneticGenetic DiseasesGenetic Predisposition to DiseaseGenotypeGoalsHormonalIncidenceInfantInfantile spasmsIntellectual functioning disabilityInterdisciplinary StudyInternationalIntractable EpilepsyKnowledgeLeadLeadershipLearningLifeMaster of Public HealthMedicalMendelian disorderMentorsMethodologyMorbidity - disease rateMuscle hypotoniaNatural HistoryNatureNeonatalNeurologistObservational StudyPathogenicityPatientsPediatric HospitalsPhasePhenotypePhosphotransferasesPilot ProjectsPopulationPrecision therapeuticsPrognosisProteinsRare DiseasesRefractoryRegression AnalysisResearchResearch DesignResearch TrainingScienceSeizuresSeveritiesSpasmSynapsesSyndromeTechniquesTestingTrainingTranslational ResearchVariantVigabatrinVisual evoked cortical potentialVulnerable PopulationsWorkbasecareer developmentchildhood epilepsyclinical biomarkersclinical careclinical diagnosisclinical epidemiologyclinical predictorsclinically relevantcohortcortical visual impairmentdesigndevelopmental diseaseexome sequencingexperiencegene panelgenetic disorder diagnosisgenetic variantimprovedinfancyketogenic dietmedical schoolsmortalitymultidisciplinaryneurogeneticsnext generation sequencingnovel diagnosticsphenotypic dataprogramsrecruitresearch studyresponseskillsstandard caretargeted treatmenttranslational approach
中文摘要
作为一名专注于癫痫遗传学的学术儿科神经学家,本次培训奖的目标是扩大Olson博士在罕见的早期遗传癫痫和基因型-表型相关性研究的临床研究方法方面的培训。此外,它旨在提高她的领导技能,专注于癫痫遗传学和CDKL5疾病的知识,以及她开发和领导多学科研究合作的转化研究的技能。培训将包括临床试验设计,以促进罕见疾病研究的下一步发展,因为她开发了一个独立的多学科研究项目,专注于CDKL5疾病和其他罕见的遗传性癫痫。拟议的培训扩展了Olson博士之前在癫痫和神经遗传学方面的培训,包括NSADA奖在内的研究经验,以及临床研究和流行病学方面的培训。这项工作将独特地汇集多学科合作者网络,使基础科学影响临床护理和临床研究,将基础科学研究集中在临床相关问题上。Olson博士的主要导师Annapurna Poduri,医学博士,公共卫生硕士,癫痫遗传学项目主任,将在临床研究,基因型-表型相关性,转化方法和联合科学方面提供指导。共同导师Tim Benke医学博士和Elizabeth Engle医学博士分别在CDKL5疾病和神经遗传学研究方面有独特的经验。这项工作将主要在波士顿儿童医院和哈佛医学院进行。Olson博士指导CDKL5疾病的三个卓越中心之一,并可以访问本地,国家和国际优秀的临床和基础科学合作者网络,以协助这项工作。新生儿和婴儿癫痫导致显著的发病率和死亡率。有越来越多的确定的遗传病因。CDKL5障碍是一种已确立的早期癫痫综合征,与特别难治性癫痫、严重发育障碍、张力低下和脑视力障碍有关。需要对遗传性癫痫(包括CDKL5疾病)的基因型-表型相关性进行稳健的表型表征和评估,以实现合理的精确治疗。鉴于其难治性,科学驱动的方法来理解和治疗CDKL5疾病将是至关重要的。本研究旨在1)确定CDKL5疾病的预测因素和流行病学定义,2)建立CDKL5疾病的基因型-表型相关性,以及3)评估CDKL5相关癫痫痉挛对标准治疗的反应。
英文摘要
As an academic pediatric neurologist focusing on epilepsy genetics, the goal of this training award is to expand Dr. Olson's training in clinical research approaches for study of rare early life genetic epilepsies and genotype- phenotype correlations. Further it aims to advance her leadership skills, focused knowledge in epilepsy genetics and CDKL5 disorder as well as her skills to develop and lead multidisciplinary research collaborations for translational research. Training will include clinical trials design to facilitate advancement to next steps in rare disease research as she develops an independent multidisciplinary research program focused on CDKL5 disorder and other rare genetic epilepsies. The proposed training expands on Dr. Olson's prior training in epilepsy and neurogenetics, research experience including an NSADA award, and training in clinical research and epidemiology. This work will uniquely bring together a multidisciplinary network of collaborators, allowing basic science to impact clinical care and clinical research to focus basic science research on clinically relevant questions. Dr. Olson's primary mentor Annapurna Poduri, M.D., M.P.H., Director of our Epilepsy Genetics Program, will provide guidance in clinical research, genotype-phenotype correlations, translational approaches, and consortium science. Co-mentors Tim Benke, M.D., Ph. D and Elizabeth Engle, M.D. each add unique experience in CDKL5 disorder and neurogenetics research, respectively. The work will be done primarily at Boston Children's Hospital and Harvard Medical School. Dr. Olson directs one of three Centers of Excellence for CDKL5 disorder, and has access to a local, national and international network of excellent clinical and basic science collaborators to assist in this work. Neonatal and infantile onset epilepsy results in significant morbidity and mortality. There are increasingly identified genetic etiologies. CDKL5 disorder is one established early life epilepsy syndrome notable for being associated with particularly refractory epilepsy, a severe developmental disorder, hypotonia and cerebral visual impairment. Robust phenotype characterization and assessment of genotype-phenotype correlations of genetic epilepsies, including CDKL5 disorder, is needed as a step towards rational precision therapy. Given its refractory nature, a scientifically driven approach to understanding and treatment will be critical in CDKL5 disorder. The proposed research study aims to 1) determine predictors and define epidemiology of CDKL5 disorder, 2) establish genotype-phenotype correlations in CDKL5 disease, and 3) evaluate response of CDKL5-associated epileptic spasms to standard treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diagnosis and Genotype-Phenotype Correlations in Early Life Epilepsy and CDKL5 Disorder
-
批准号:10758725
-
项目类别:
-
资助金额:$23.13万
-
财政年份:2023
-
负责人:Heather Elisa Olson
-
依托单位:
Diagnosis and genotype-phenotype correlations in early life epilepsy and CDKL5 disorder
-
批准号:9893040
-
项目类别:
-
资助金额:$19.82万
-
财政年份:2018
-
负责人:Heather Elisa Olson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: